【摘要】 目的　研究双介入疗法治疗原发性肝癌的临床疗效。　方法　首先行TACE术 ,1～ 3周后在B超或CT引导下行PEIT治疗 ,每周行 (1～ 2 )次 ,连续 (3～ 5 )次。　结果　全组共行TACE 6 1人次 ,PEIT96人次。全组CR 3例 ,PR 12例 ,有效率 (CR +PR) 4 8.4 % (15 / 31) ,NC 10例 ,PD 6例。全组 1、2、3、4年生存率分别为 82 .8%、6 1.0 %、4 8.8%、4 0 .7%。　结论　双介入疗法对部分不能手术治疗的原发性肝癌是一种较安全、有效的治疗手段更多还原

【Abstract】 Objective To study the therapeutic effectiveness of combined therapy of chemoembolization and ethanol injection for advanced primary liver cancer. Methods First all cases were treated with Transcatheter Arterial Chemoembolization (TACE), and were treated with Percutaneous Ethanol Injection therapy (PEIT) 1w～3w after TACE. The PEIT was taken 1-2 times a week and 3-5 times in all. Results TACE was performed in 61 patient-times and PEIT 96 patient-times in all cases. The complete response (CR) was in 3 cases, partial response (PR) in 12 cases, no change (NC) 10 cases and progressive disease (PD) in 6 cases. The effective rate (CR+PR) was 48.4% (15/31). The 1-,2-,3- and 4-year survival rates were 82.8%, 61.0%, 48.8% and 40.7% respectively. Conclusions Combined therapy of TACE and PEIT is effective method for a part of advanced unresectable primary liver cancer.更多还原